Evidence map›Paper›PMID 36014801›Full record

ArticleNutrients2022

Effect of Maternal Glucose and Triglyceride Levels during Early Pregnancy on Pregnancy Outcomes: A Retrospective Cohort Study.

Dandan Wu, Jianlin Zhang, Yimeng Xiong, Hui Wang, Danyang Lu, Mengxi Guo, Jian Zhang, Lei Chen, Jianxia Fan, Hefeng Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dandan WuThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Jianlin ZhangObstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200090, China.
Yimeng XiongThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Hui WangDepartment of Obstetrics and Gynecology, Maternity and Child Health Hospital of Songjiang District, Shanghai 201620, China.
Danyang LuThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Mengxi GuoThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Jian ZhangThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Lei ChenThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Jianxia FanThe International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.ORCID 0000-0003-3338-877X
Hefeng HuangObstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200090, China.
Xianhua LinObstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200090, China.ORCID 0000-0003-0002-6414
Shanghai Jiao Tong University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNObstetrics and Gynecology Hospital of Fudan University · CN

Funding

CAMS Innovation Fund for Medical Sciences 2019-I2M-5-064Clinical Research Plan of SHDC SHDC2020CR1008A;SHDC12019X17Collaborative Innovation Program of Shanghai Municipal Health Commission 2020CXJQ01International Cooperation Project of China and Canada NSFC 81661128010Multicentre clinical research project of Shanghai Jiao Tong University, School of Medicine DLY201827National Natural Science Foundation of China 82088102;81801541;82071730The Interdisciplinary Key Program of Shanghai Jiao Tong University YG2014ZD08The major program of the National Natural Science Foundation of China 81490742The National Key Research and Development Program of China 2017YFC1001300;2018YFC1005001Three-year Action Plan to Promote Clinical Skills and Innovation in Municipal Hospitals SHDC2020CR4094
6 · The paper itself

Abstract

Maternal dysglycemia and lipid metabolic dysfunction have been recognized as risk factors for pregnancy complications and adverse perinatal outcome jointly and separately, but current diagnostic window-period which is at the end of the second trimester might be late to avoid chronic adverse impacts on both mother and fetus. A retrospective cohort study involving 48,973 women with fasting blood glucose (FPG) below diagnostic thresholds and lipid screening in early pregnancy was performed. Data of pregnancy outcomes including gestational diabetes mellitus (GDM), hypertensive disorders in pregnancy (HDP), and neonatal outcomes were obtained for multivariable logistic analysis. As a result, higher FPG (≥75th, 4.68 mM) significantly increased risks of GDM (Adjusted odds ratio (AOR), 2.81; 95% CI, 2.60 to 3.05) and HDP (1.98; 1.81 to 2.16), and slightly increased risks of large for gestational age (LGA), macrosomia births and neonatal intensive care unit (NICU) compared to women with low FPG (≤25th, 4.21 mM). High maternal triglyceride (mTG) level had higher risks of GDM and HDP in all maternal FPG strata. Further analysis showed that women of top quartile of glucose combined with upper 10 percentile triglyceride have higher risks for GDM (AOR, 5.97; 95% CI, 5.26 to 6.78; risk difference 30.8, 95% CI 29.2 to 32.3) and HDP (AOR, 2.56; 95% CI, 2.20 to 2.99, risk difference 11.3, 95% CI 9.9 to 12.7) when compared to those in women of the bottom strata after adjustment. Therefore, both the early-pregnancy FPG and mTG levels should be screened among overall population including the low-risk population to reduce the incidence of pregnancy complications.

Indexed as

Diabetes, GestationalPregnancy ComplicationsFemaleFetal MacrosomiaGlucoseHumansInfant, NewbornPregnancyPregnancy OutcomeRetrospective StudiesTriglyceridesWeight GainGlucoseTriglyceridesgestational diabetes mellitushypertensive disorders in pregnancymaternal and infant outcomesmaternal dysglcemiamaternal triglyceride

Identifiers

PMID36014801
PMCPMC9414844
OpenAlexW4290999206

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.